Asenapine Patch Adhesive Composition for N-Oxide Suppression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Asenapine can be oxidized to generate asenapine-N-oxide during the manufacturing process of patches, which reduces the stability and effectiveness of the patch over time.

Innovation Solution

Incorporating thiosulfates, sulfites, or pyrosulfites into the adhesive composition of the patch, which includes asenapine or its pharmaceutically acceptable salt and an adhesive base, to suppress the generation of asenapine-N-oxide.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If asenapine is used in patch manufacturing without additional stabilizing agents, then the manufacturing process is simple, but asenapine-N-oxide is generated during manufacturing and storage, reducing product stability

Engineering Contradiction:
Improvemanufacturing simplicityVSAvoidproduct stability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

Thiosulfates, sulfites, or pyrosulfites are introduced as intermediary substances that mediate between asenapine and oxidizing agents. These additives preferentially react with oxidizing agents or create a reducing environment, preventing direct oxidation of asenapine to asenapine-N-oxide while maintaining manufacturing simplicity

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The chemical environment parameters of the adhesive composition are changed by adding thiosulfates, sulfites, or pyrosulfites. These substances alter the oxidation-reduction potential and chemical reactivity parameters of the system, creating conditions that suppress asenapine oxidation while maintaining manufacturing process simplicity

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If asenapine is stored in patch form without stabilizing agents, then storage handling is simple, but asenapine-N-oxide accumulates over time, reducing pharmacological effectiveness

Engineering Contradiction:
Improvestorage handling simplicityVSAvoidpharmacological effectiveness
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

Thiosulfates, sulfites, or pyrosulfites are incorporated into the adhesive composition during manufacturing as preliminary protective measures. These substances are pre-positioned to act against potential oxidation during storage, preventing asenapine-N-oxide formation before it can occur during the storage period

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The potential harmful oxidation that would normally occur during storage is converted into a beneficial protective mechanism. Thiosulfates, sulfites, or pyrosulfites act as sacrificial reducing agents that can be oxidized instead of asenapine, transforming the harmful oxidative environment into a protected state that maintains pharmacological effectiveness

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The addition of thiosulfates, sulfites, or pyrosulfites effectively reduces the generation of asenapine-N-oxide to 0.05% or less immediately after patch manufacture and 0.25% or less after storage, thereby maintaining the patch's stability and pharmacological effectiveness.

Implementation Method 1

Asenapine can be oxidized to generate asenapine-N-oxide in the process of manufacturing the patch

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

adding at least one selected from the group consisting of thiosulfates, sulfites, and pyrosulfites to a composition comprising an adhesive base and asenapine or a pharmaceutically acceptable salt thereof

Methodology Applied
Scientific EffectReduction: Reduction

Data Source

PatentUS12343329B2Method for suppressing production of asenapine-N-oxide
Publication Date: 2025.07.01 HISAMITSU PHARM CO INC
  • US12343329B2 patent drawing

AI summary

The present invention provides a patch comprising an adhesive layer on a backing, the adhesive layer comprising: asenapine or a pharmaceutically acceptable salt thereof; an adhesive base; and at least one selected from the group consisting of thiosulfates, sulfites, and pyrosulfites.